An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs ...

Bio corporation Alteogen announced on the 22nd that its integrated entity 'Alteogen Biologics,' formed by merging its subsidiary Alteogen Healthcare and Altos Biologics, is launching. The company ...

A link to the live and archived webcasts may be accessed on the Unicycive website under the Investors section: Events and ...

Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to stopping aging ...

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) (“Unicycive” or the “Company”), a clinical stage biotechnology company developing ...

Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...